Michael S. Hearne
CIK: 0001759910
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AUPH
Aurinia Pharmaceuticals Inc.
Officer
Discretionary Trading P&L
Holdings
About Hearne Michael S
Hearne Michael S (SEC CIK 0001759910) files insider reports with the SEC as Chief Financial Officer of Aurinia Pharmaceuticals Inc. (AUPH).
Signal8 holds 2 ownership filings by Hearne Michael S (1 Form 3, 1 Form 4), filed between Apr 2, 2026 and May 20, 2026. Those filings report 1 transaction, the latest on May 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hearne Michael S's filings is in EDMONTON.
Recent filings by Hearne Michael S
- May 18, 2026: Grant or award of AUPH shares (Form 4, code A).
Other insiders filing for Aurinia Pharmaceuticals Inc. (AUPH)
- Robertson Stephen P., Chief Legal Officer
- Johnson Craig A, Director
- Goetz Kathleen, Director
- Nova Tina Susan, Director
- Bailey Jeffrey Allen, Director
- TANG KEVIN, Chief Executive Officer